[HTML][HTML] Early Alzheimer's disease pathology in human cortex is associated with a transient phase of distinct cell states
V Gazestani, T Kamath, NM Nadaf, SJ Burris, B Rooney… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Cellular perturbations underlying Alzheimer's disease are primarily studied in human
postmortem samples and model organisms. Here we generated a single-nucleus atlas from …
postmortem samples and model organisms. Here we generated a single-nucleus atlas from …
Basal forebrain cholinergic dysfunction in Alzheimer's disease–interrelationship with β-amyloid, inflammation and neurotrophin signaling
R Schliebs - Neurochemical research, 2005 - Springer
Alzheimer's disease, the most common neurodegenerative disorder of senile dementia, is
characterized by two major morpho-pathological hallmarks. Deposition of extracellular …
characterized by two major morpho-pathological hallmarks. Deposition of extracellular …
Targeting synaptic dysfunction in Alzheimer's disease therapy
R Nisticò, M Pignatelli, S Piccinin, NB Mercuri… - Molecular …, 2012 - Springer
In the past years, major efforts have been made to understand the genetics and molecular
pathogenesis of Alzheimer's disease (AD), which has been translated into extensive …
pathogenesis of Alzheimer's disease (AD), which has been translated into extensive …
Locus coeruleus integrity and left frontoparietal connectivity provide resilience against attentional decline in preclinical alzheimer's disease
J Pahl, PC Prokopiou, E Bueichekú, AP Schultz… - Alzheimer's Research & …, 2024 - Springer
Autopsy work reported that neuronal density in the locus coeruleus (LC) provides neural
reserve against cognitive decline in dementia. Recent neuroimaging and pharmacological …
reserve against cognitive decline in dementia. Recent neuroimaging and pharmacological …
Conserved cell-type specific signature of resilience to Alzheimer's disease nominates role for excitatory intratelencephalic cortical neurons
Summary Alzheimer's disease (AD), the leading cause of dementia, affects millions of
people worldwide. With no disease-modifying medication currently available, the human toll …
people worldwide. With no disease-modifying medication currently available, the human toll …
Medial prefrontal cortex pyramidal neurons exhibit functional defects during early stage of Alzheimer's disease in 3xTg‐AD mice
N Choudhury, L Chen, VT Nguyen… - Alzheimer's & …, 2021 - Wiley Online Library
Background The brain regions that show early increase of beta‐amyloid (Aβ) in Alzheimer's
disease (AD) overlap with the default mode network (DMN)(Palmqvist, S. et. al., 2017) …
disease (AD) overlap with the default mode network (DMN)(Palmqvist, S. et. al., 2017) …
Disrupted muscarinic M1 receptor signaling correlates with loss of protein kinase C activity and glutamatergic deficit in Alzheimer's disease
SWY Tsang, J Pomakian, GA Marshall, HV Vinters… - Neurobiology of …, 2007 - Elsevier
There are few studies on the clinical and neurochemical correlates of postsynaptic
cholinergic dysfunction in Alzheimer's disease (AD). We have previously found that …
cholinergic dysfunction in Alzheimer's disease (AD). We have previously found that …
Reply: Optimal use of cholinergic drugs in Alzheimer's disease
H Hampel, E Cavedo, A Vergallo… - Brain, 2018 - academic.oup.com
Sir, We agree with the suggestions of Gauthier and colleagues (Gauthier et al., 2018) for a
more structured approach to therapy in Alzheimer's disease. We also agree that there is …
more structured approach to therapy in Alzheimer's disease. We also agree that there is …
When acetylcholine unlocks feedback inhibition in cortex
Acetylcholine promotes cognitive function through the regulation of cortical circuits. In this
issue of Neuron, Urban-Ciecko et al.(2018) demonstrate how this neuromodulator can …
issue of Neuron, Urban-Ciecko et al.(2018) demonstrate how this neuromodulator can …
Neuromodulatory control of hippocampal function: towards a model of Alzheimer's disease
ED Menschik, LH Finkel - Artificial intelligence in medicine, 1998 - Elsevier
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of cognitive function
whose cellular pathology and molecular etiology have been increasingly and dramatically …
whose cellular pathology and molecular etiology have been increasingly and dramatically …